Structural Basis of Resistance to Anti-Cytochrome bc1 Complex Inhibitors: Implication for Drug Improvement

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|5|704-724

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.5, 2014-02, pp. : 704-724

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structural Basis for Drug Resistance Mechanisms Against EGFR

By  

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 22, 2017-07 ,pp. : 2509-2521

Bentham Science Publishers

Access to resources Recommend Favorite

Possible Effects of Early Treatments of Hsp90 Inhibitors on Preventing the Evolution of Drug Resistance to Other Anti-Cancer Drugs

By  

Current Medicinal Chemistry, Vol. 14, Iss. 2, 2007-01 ,pp. : 223-232

Bentham Science Publishers

Access to resources Recommend Favorite

Overcoming the Drug Resistance Problem with Second-Generation Tyrosine Kinase Inhibitors: From Enzymology to Structural Models

By  

Current Medicinal Chemistry, Vol. 18, Iss. 19, 2011-06 ,pp. : 2836-2847

Bentham Science Publishers

Access to resources Recommend Favorite

Structural Basis and Therapeutic Implication of the Interaction of CCN Proteins with Glycoconjugates

By  

Current Pharmaceutical Design, Vol. 10, Iss. 31, 2004-12 ,pp. : 3913-3928

Bentham Science Publishers

Access to resources Recommend Favorite

Structural and Thermodynamic Basis of Resistance to HIV-1 Protease Inhibition: Implications for Inhibitor Design

By  

Current Drug Targets - Infectious Disorders, Vol. 3, Iss. 4, 2003-12 ,pp. : 311-328

Bentham Science Publishers

Access to resources Recommend Favorite